Between February and November 2022, the cervical cancer screening program was introduced in the Caribbean Netherlands: first on Saba, then on Sint 
Eustatius and finally on Bonaire.

The first results are: 

• a properly set up screening process on each island that is tailored to that island’s specific situation;
• the availability of information materials, allowing people to make an informed decision about participation;
• training or refresher courses for those who perform the cervical swab tests on all islands;
• all analyses are performed by a single accredited laboratory on Curaçao. This laboratory carries out both the test for the human papilloma virus (HPV typing) and 
  the cytology test for cancer cells;
• a number of tasks have been delegated to local and regional partners, such as information provision and sampling. The RIVM screening organization remains 
  responsible for monitoring the entire screening process;
• a screening process that follows the guidelines applicable in the European Netherlands as much as possible